Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.11 Million ≈ $6.60 Million USD) by net assets (CN¥1.88 Billion ≈ $274.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Shandong Bailong Chuangyuan Bio-Tech Co. to measure how much of total assets are equity-financed.

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shandong Bailong Chuangyuan Bio-Tech Co. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Formula TA:FORTY	0.230x
Orora Ltd AU:ORA	0.082x
Compass Pathways Plc NASDAQ:CMPS	0.715x
LIBERTY LAT.AMER.C DL-01 F:1LLC	0.434x
Bomin Electronics Co Ltd SHG:603936	0.009x
Global Brands Manufacture Ltd TW:6191	0.059x
Lanzhou LS Heavy Equipment Co SHG:603169	-0.003x
Centuria Industrial REIT AU:CIP	0.020x

Annual Cash Flow Conversion Efficiency for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Shandong Bailong Chuangyuan Bio-Tech Co. stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.96 Billion ≈ $287.02 Million	CN¥135.45 Million ≈ $19.82 Million	0.069x	-61.46%
2024-12-31	CN¥1.68 Billion ≈ $245.73 Million	CN¥300.89 Million ≈ $44.03 Million	0.179x	+38.81%
2023-12-31	CN¥1.51 Billion ≈ $220.64 Million	CN¥194.63 Million ≈ $28.48 Million	0.129x	+15.88%
2022-12-31	CN¥1.34 Billion ≈ $196.81 Million	CN¥149.82 Million ≈ $21.92 Million	0.111x	+39.36%
2021-12-31	CN¥1.20 Billion ≈ $176.10 Million	CN¥96.20 Million ≈ $14.08 Million	0.080x	-54.65%
2020-12-31	CN¥691.09 Million ≈ $101.13 Million	CN¥121.82 Million ≈ $17.83 Million	0.176x	+64.25%
2019-12-31	CN¥597.07 Million ≈ $87.37 Million	CN¥64.08 Million ≈ $9.38 Million	0.107x	-39.58%
2018-12-31	CN¥501.71 Million ≈ $73.42 Million	CN¥89.12 Million ≈ $13.04 Million	0.178x	-31.68%
2017-12-31	CN¥436.41 Million ≈ $63.86 Million	CN¥113.47 Million ≈ $16.60 Million	0.260x	+56.90%
2016-12-31	CN¥362.67 Million ≈ $53.07 Million	CN¥60.10 Million ≈ $8.79 Million	0.166x	--

About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.

SHG:605016 China Packaged Foods

Market Cap

$1.34 Billion

CN¥9.13 Billion CNY

Market Cap Rank

#7680 Global

#1711 in China

Share Price

CN¥21.74

Change (1 day)

-0.05%

52-Week Range

CN¥18.88 - CN¥28.42

All Time High

CN¥29.93